Hemodynamic characteristics of the centrally mediated pressor activities of angiotensin.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000804:Angiotensin II / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002302:Cardiac Output / Q000187:drug effects; D002339:Carotid Arteries / Q000187:drug effects; D004285:Dogs; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D011433:Propranolol / Q000494:pharmacology; D011651:Pulmonary Artery / Q000187:drug effects; D013233:Stellate Ganglion / Q000502:physiology; D013268:Stimulation, Chemical; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014711:Vertebral Artery
D000319:Adrenergic beta-Antagonists; D014662:Vasoconstrictor Agents; D000804:Angiotensin II; D011433:Propranolol